MX2007015255A - Metodo y composicion para administracion transdermica de un farmaco. - Google Patents

Metodo y composicion para administracion transdermica de un farmaco.

Info

Publication number
MX2007015255A
MX2007015255A MX2007015255A MX2007015255A MX2007015255A MX 2007015255 A MX2007015255 A MX 2007015255A MX 2007015255 A MX2007015255 A MX 2007015255A MX 2007015255 A MX2007015255 A MX 2007015255A MX 2007015255 A MX2007015255 A MX 2007015255A
Authority
MX
Mexico
Prior art keywords
composition
testosterone
active agent
drug delivery
transdermal drug
Prior art date
Application number
MX2007015255A
Other languages
English (en)
Spanish (es)
Inventor
Igor Gonda
Tony Di Pietro
Andrew Humberstone
Adam Watkinson
Monique Robinson
Kerrie Setiawan
Carolyn Stone
Nina Wilkins
Original Assignee
Acrux Dds Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37481160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007015255(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2005902902A external-priority patent/AU2005902902A0/en
Application filed by Acrux Dds Pty Ltd filed Critical Acrux Dds Pty Ltd
Publication of MX2007015255A publication Critical patent/MX2007015255A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/411—Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
MX2007015255A 2005-06-03 2006-06-02 Metodo y composicion para administracion transdermica de un farmaco. MX2007015255A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2005902902A AU2005902902A0 (en) 2005-06-03 Method for transdermal drug delivery
US75288405P 2005-12-23 2005-12-23
PCT/AU2006/000763 WO2006128255A1 (en) 2005-06-03 2006-06-02 Method and composition for transdermal drug delivery

Publications (1)

Publication Number Publication Date
MX2007015255A true MX2007015255A (es) 2008-02-22

Family

ID=37481160

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007015255A MX2007015255A (es) 2005-06-03 2006-06-02 Metodo y composicion para administracion transdermica de un farmaco.

Country Status (7)

Country Link
EP (1) EP1896038B1 (enExample)
JP (2) JP5401092B2 (enExample)
KR (1) KR101344342B1 (enExample)
CA (1) CA2610708C (enExample)
EA (1) EA019214B1 (enExample)
MX (1) MX2007015255A (enExample)
WO (1) WO2006128255A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019214B1 (ru) * 2005-06-03 2014-02-28 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Способ лечения или профилактики заболеваний, вызванных дефицитом андрогенов у взрослых мужчин
MX2009007366A (es) 2007-01-11 2009-07-16 Acrux Dds Pty Ltd Implemento para untar.
ES2494853T3 (es) * 2007-11-02 2014-09-16 Acrux Dds Pty Ltd Sistema de administración transdérmica
CN102348448A (zh) * 2009-03-11 2012-02-08 Isp投资公司 增稠添加剂组合物
US20120294818A1 (en) * 2009-03-11 2012-11-22 Isp Investments Inc. Antiperspirant Compositions
FR2964323B1 (fr) * 2010-09-08 2012-11-09 Jean Pierre Raynaud Utilisation de la testosterone chez un patient en deficit androgenique et atteint d'un cancer de la prostate
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
KR20200118228A (ko) * 2011-05-15 2020-10-14 에이세러스 바이오파마 인크. 비내용 테스토스테론 바이오-접착제 겔 제형 및 남성의 성선기능저하증을 치료하기 위한 그의 용도
CN103619403B (zh) 2011-06-27 2019-04-19 辉凌公司 将粘性液体涂敷到人皮肤的涂敷器系统
EP3817731B1 (en) * 2018-07-05 2025-09-03 Celista Pharmaceuticals Llc Testosterone and estradiol transdermal spray

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1192003A (en) * 1966-05-25 1970-05-13 Struthers Scientific Int Corp Improvements in or relating to Hair Dressing Preparation
DK534178A (da) 1977-12-16 1979-06-17 Interx Research Corp Anticholinerge midler med sektrtionshaemmende virkning
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6923983B2 (en) * 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
JP2001270826A (ja) * 1999-09-28 2001-10-02 Shoei:Kk 皮膚疾患治療・予防用外用剤
US6562790B2 (en) 2000-02-05 2003-05-13 Chein Edmund Y M Hormone therapy methods and hormone products for abating coronary artery blockage
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
EP2283865A1 (en) * 2000-08-30 2011-02-16 Unimed Pharmaceuticals, LLC Method of increasing testosterone and related steroid concentrations in women
CA2419573C (en) * 2000-08-30 2007-04-03 Unimed Pharmaceuticals, Inc. Method of increasing testosterone and related steroid concentrations in women
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6743448B2 (en) 2000-12-11 2004-06-01 Abraham H. Kryger Topical testosterone formulations and associated methods
CN100335081C (zh) * 2002-01-26 2007-09-05 Mst有限公司 含有牡丹根皮提取物作为活性成分的组合物
AU2003228314C1 (en) * 2002-03-15 2009-03-26 Besins Healthcare Luxembourg Sarl Androgen pharmaceutical composition and method for treating depression
CA2489865C (en) * 2002-06-25 2012-05-08 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
EP1594545B1 (fr) * 2003-02-20 2008-11-12 Besins International Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
EP1684761A1 (en) * 2003-11-19 2006-08-02 Acrux DDS Pty Ltd Method and composition for treatment or prophylaxis of amyloidosis disorders
US9180081B2 (en) * 2005-03-03 2015-11-10 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
ZA200707351B (en) * 2005-03-03 2010-02-24 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of an oligopeptide
EA019214B1 (ru) * 2005-06-03 2014-02-28 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Способ лечения или профилактики заболеваний, вызванных дефицитом андрогенов у взрослых мужчин

Also Published As

Publication number Publication date
WO2006128255A1 (en) 2006-12-07
CA2610708A1 (en) 2006-12-07
EP1896038A1 (en) 2008-03-12
EP1896038A4 (en) 2012-02-22
JP2008542306A (ja) 2008-11-27
CA2610708C (en) 2013-10-08
EP1896038B1 (en) 2016-11-09
JP2013237690A (ja) 2013-11-28
JP5401092B2 (ja) 2014-01-29
EA200702636A1 (ru) 2008-06-30
KR20080033232A (ko) 2008-04-16
EA019214B1 (ru) 2014-02-28
KR101344342B1 (ko) 2013-12-24

Similar Documents

Publication Publication Date Title
US9180194B2 (en) Method and composition for transdermal drug delivery
KR101301116B1 (ko) 분산 기구
AU706967B2 (en) Dermal penetration enhancers and drug delivery systems involving same
JP5737942B2 (ja) 経皮送達システム
KR101344342B1 (ko) 경피 약물 전달 방법 및 조성물
AU2006254742B2 (en) Method and composition for transdermal drug delivery
AU2011202787B2 (en) Method and composition for transdermal drug delivery
HK1115300A (en) Method and composition for testosterone transdermal delivery
HK1115300B (en) Method and composition for testosterone transdermal delivery
AU2006247934A1 (en) Low dose administration of a topical composition

Legal Events

Date Code Title Description
FG Grant or registration